The article offers information on the report released by the U.S. Centers for Disease Control & Prevention on July 13, 2011 regarding the use of antiretroviral drugs with Truvada brand as pre-exposure prophylaxis...
吉列德科学和美CDC就HIV事先预防(PrEP)药的专利归属首次互撕在公堂!美CDC于2019就起诉吉列德科学没支付PrEP的2个口服药专利费,GILD对此说法坚决予以否认;CDC科学家在新的千禧第一个10年发现,2种抗艾药emtricitabine和tenofovir组合在一起,可高效预防HIV感染;吉列德科学的Truvada和Descovy均含emtricitabine/tenofovir,202...
美CDC数据显示!新冠疫情严重影响艾滋检测与PrEP处方的正常开具! 根据MMWR公布的数据,在新冠肺炎大流行的最初几个月,美国全国HIV检测下降了近三分之一,PrEP的处方数也受到了负面影响。 专家们在疫情爆发的第一年警告说,新冠肺炎疫情导致艾滋病服务中断,使艾滋病防治目标进一步偏离轨道,研究表明,艾滋病病毒和其他性传播...
根据美国国家HIV行为监测系统的最新数据显示,从2017年到2023年,知晓PrEP的同性恋和双性恋男性比例从85%增加到93%,而使用PrEP的比例也从25%增加到45%。 自2019年实施“结束HIV流行”计划以来,符合条件的人群中PrEP的处方数量也有所增加。 然而,PrEP的推广仍然存在不均衡,特别是在种族和民族之间存在显著差异。 虽然黑...
PrEP 是一种新的为HIV阴性的人群设计的药。每天一颗,一周到两周后开始奏效。每天吃这个药可以使HIV阴性的人跟阳性的人有性接触也不会感染,99%的保护率。美国FDA已经批准两年多了并且鼓励HIV高危人群持续服用。中国似乎还知名度不是很高。现在应该还在医药公司的专利期内所以价格不低,但是专利期过后有望降低。相关...
CDC-FUNDED HIV TESTING AND HIV SERVICE DELIVERY TO RACIAL AND ETHNIC MINORITY PATIENTS ATTENDING STD CLINICS IN THE UNITED STATES: ASSOCIATIONS WITH MEDICA... Gilford,John,Hogben,... - 《Sexually Transmitted Diseases》 被引量: 0发表: 2016年 Opening up their doors: perspectives on the ...
"PrEP is a new approach to HIV prevention that requires continuing collaboration between patients and providers, as effectiveness requires adherence to daily medication and regular medical visits for monitoring, counseling and testing," Smith said. ...
The event focused on HIV testing intervention and laboratory technology. The Chinese representatives introduced the latest practice and study such as the online HIV VCT model, pre-exposureprophylaxis (PrEP), civil society organization participation, combining of traditional ...
Human immunodeficiency virus (HIV) preexposure prophylaxis (PrEP) has high biomedical efficacy; however, awareness, access, uptake, and persistence on ther... DP Serota,ES Rosenberg,AM Lockard,... - 《Clinical Infectious Diseases》 被引量: 2发表: 2018年 HIV testing trends and correlates among...
HIV testing venues The potential impact of PrEP implementation at CDC-funded nonclinical HIV testing venuesThe potential impact of PrEP implementation at CDC-funded nonclinical HIV testing venuesVanessa M Kung